Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Paul Castillo-Caro"'
Autor:
Aleksandr Lazaryan, Michelle Dolan, Mei-Jie Zhang, Hai-Lin Wang, Mohamed A. Kharfan-Dabaja, David I. Marks, Nelli Bejanyan, Edward Copelan, Navneet S. Majhail, Edmund K. Waller, Nelson Chao, Tim Prestidge, Taiga Nishihori, Partow Kebriaei, Yoshihiro Inamoto, Betty Hamilton, Shahrukh K. Hashmi, Rammurti T. Kamble, Ulrike Bacher, Gerhard C. Hildebrandt, Patrick J. Stiff, Joseph McGuirk, Ibrahim Aldoss, Amer M. Beitinjaneh, Lori Muffly, Ravi Vij, Richard F. Olsson, Michael Byrne, Kirk R. Schultz, Mahmoud Aljurf, Matthew Seftel, Mary Lynn Savoie, Bipin N. Savani, Leo F. Verdonck, Mitchell S. Cairo, Nasheed Hossain, Vijaya Raj Bhatt, Haydar A. Frangoul, Hisham Abdel-Azim, Monzr Al Malki, Reinhold Munker, David Rizzieri, Nandita Khera, Ryotaro Nakamura, Olle Ringdén, Marjolein van der Poel, Hemant S. Murthy, Hongtao Liu, Shahram Mori, Satiro De Oliveira, Javier Bolaños-Meade, Mahmoud Elsawy, Pere Barba, Sunita Nathan, Biju George, Attaphol Pawarode, Michael Grunwald, Vaibhav Agrawal, Youjin Wang, Amer Assal, Paul Castillo Caro, Yachiyo Kuwatsuka, Sachiko Seo, Celalettin Ustun, Ioannis Politikos, Hillard M. Lazarus, Wael Saber, Brenda M. Sandmaier, Marcos De Lima, Mark Litzow, Veronika Bachanova, Daniel Weisdorf
Publikováno v:
Haematologica, Vol 106, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/5f4f65fecf5144b8af57be068ff20e60
Autor:
Aleksandr Lazaryan, Michelle Dolan, Mei-Jie Zhang, Hai-Lin Wang, Mohamed A. Kharfan-Dabaja, David I. Marks, Nelli Bejanyan, Edward Copelan, Navneet S. Majhail, Edmund K. Waller, Nelson Chao, Tim Prestidge, Taiga Nishihori, Partow Kebriaei, Yoshihiro Inamoto, Betty Hamilton, Shahrukh K. Hashmi, Rammurti T. Kamble, Ulrike Bacher, Gerhard C. Hildebrandt, Patrick J. Stiff, Joseph McGuirk, Ibrahim Aldoss, Amer M. Beitinjaneh, Lori Muffly, Ravi Vij, Richard F. Olsson, Michael Byrne, Kirk R. Schultz, Mahmoud Aljurf, Matthew Seftel, Mary Lynn Savoie, Bipin N. Savani, Leo F. Verdonck, Mitchell S. Cairo, Nasheed Hossain, Vijaya Raj Bhatt, Haydar A. Frangoul, Hisham Abdel-Azim, Monzr Al Malki, Reinhold Munker, David Rizzieri, Nandita Khera, Ryotaro Nakamura, Olle Ringdén, Marjolein van der Poel, Hemant S. Murthy, Hongtao Liu, Shahram Mori, Satiro De Oliveira, Javier Bolaños-Meade, Mahmoud Elsawy, Pere Barba, Sunita Nathan, Biju George, Attaphol Pawarode, Michael Grunwald, Vaibhav Agrawal, Youjin Wang, Amer Assal, Paul Castillo Caro, Yachiyo Kuwatsuka, Sachiko Seo, Celalettin Ustun, Ioannis Politikos, Hillard M. Lazarus, Wael Saber, Brenda M. Sandmaier, Marcos De Lima, Mark Litzow, Veronika Bachanova, Daniel Weisdorf, Acute Leukemia Committee of the CIBMTR
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Cytogenetic risk stratification at diagnosis has long been one of the most useful tools to assess prognosis in acute lymphoblastic leukemia (ALL). To examine the prognostic impact of cytogenetic abnormalities on outcomes after allogeneic hematopoieti
Externí odkaz:
https://doaj.org/article/0a9dd539d4d7436794f9d085bd9329f3
Autor:
Catherine M. Bollard, Malcolm K. Brenner, Helen E. Heslop, Kathryn Leung, Robert A. Krance, Carlos A. Ramos, George Carrum, Eric Yvon, Barbara Savoldo, Aaron Foster, Sawa Ito, A. John Barrett, Jos Melenhorst, Hao Liu, Meng-Fen Wu, Yasmin Hazrat, Paul Castillo-Caro, Stephanie Ku, Alana A. Kennedy-Nasser
PDF file - 63KB, Supplemental Table 1. Recipients of MRD Grafts who did not receive ULD-IL-2 Supplemental Table 2. Recipients of MUD Grafts who did not receive ULD-IL-2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c072e8a001181ce17dd98a74ce033f1
https://doi.org/10.1158/1078-0432.22455680.v1
https://doi.org/10.1158/1078-0432.22455680.v1
Autor:
Catherine M. Bollard, Malcolm K. Brenner, Helen E. Heslop, Kathryn Leung, Robert A. Krance, Carlos A. Ramos, George Carrum, Eric Yvon, Barbara Savoldo, Aaron Foster, Sawa Ito, A. John Barrett, Jos Melenhorst, Hao Liu, Meng-Fen Wu, Yasmin Hazrat, Paul Castillo-Caro, Stephanie Ku, Alana A. Kennedy-Nasser
Purpose: GVHD after allogeneic hematopoietic stem cell transplantation (alloSCT) has been associated with low numbers of circulating CD4+CD25+FoxP3+ regulatory T cells (Tregs). Because Tregs express high levels of the interleukin (IL)-2 receptor, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ef41f17b29dc60cb33557b2c04c92b
https://doi.org/10.1158/1078-0432.c.6523082
https://doi.org/10.1158/1078-0432.c.6523082
Autor:
Catherine M. Bollard, Malcolm K. Brenner, Helen E. Heslop, Kathryn Leung, Robert A. Krance, Carlos A. Ramos, George Carrum, Eric Yvon, Barbara Savoldo, Aaron Foster, Sawa Ito, A. John Barrett, Jos Melenhorst, Hao Liu, Meng-Fen Wu, Yasmin Hazrat, Paul Castillo-Caro, Stephanie Ku, Alana A. Kennedy-Nasser
PDF file - 26KB, General Immune reconstitution. Immune reconstitution was evaluated in individual patients after transplant. Phenotyping was performed on PBMC to evaluate for the presence of NK cells (A), CD8+ T-cells (B), CD4+ T cells (C), B cells (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9279eac1289b3c353f852fecdbb58611
https://doi.org/10.1158/1078-0432.22455683.v1
https://doi.org/10.1158/1078-0432.22455683.v1
Autor:
Carlos Rinaldi, Angelie Rivera-Rodriguez, Lan Hoang-Minh, Duane Mitchell, Christina von Roemeling, Fernanda Pohl-Guimarães, Paul Castillo-Caro, Kevin J. Otto, Seth Currlin
Publikováno v:
Neuro Oncol
SIGNIFICANCE Adoptive T cell therapy (ACT) has emerged as the most effective treatment against advanced malignant melanoma, eliciting remarkable objective clinical responses in up to 75% of patients with refractory metastatic disease, including withi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0ccd0c1fc3a1b13d05299c8c36078e
https://europepmc.org/articles/PMC7651156/
https://europepmc.org/articles/PMC7651156/
Autor:
Bikash Sahay, Brian Stover, Matthew R. Sarkisian, Sheila Carrera-Justiz, Elias Sayour, Gabriel De Leon, Aida Karachi, Maryam Rahman, Héctor R. Méndez-Gómez, Brandon Wummer, Loic P. Deleyrolle, Kristianna Fredenburg, Paul Castillo-Caro, Adam Grippin, Ginger Moore, Duane Mitchell, Jianping Huang
Publikováno v:
Nano Letters. 18:6195-6206
Translation of nanoparticles (NPs) into human clinical trials for patients with refractory cancers has lagged due to unknown biologic reactivities of novel NP designs. To overcome these limitations, simple well-characterized mRNA lipid-NPs have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7eba09b1a3fe8e00e155520b9db388
https://doi.org/10.1021/acs.nanolett.8b02179
https://doi.org/10.1021/acs.nanolett.8b02179
Autor:
Elizabeth Ogando-Rivas, Paul Castillo-Caro, Anjelika Dechkovskaia, Duane Mitchell, Noah Jones, Changlin Yang
Publikováno v:
Neuro Oncol
INTRODUCTION There are a few alternatives treatments beside the standard care for glioblastomas, one of them is adoptive cell therapy; our group has shown promising preliminary results with a dendritic cell-based vaccine that has being tested in firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d814eda02991cb204161c87ca87b8a
https://doi.org/10.1093/neuonc/noaa215.459
https://doi.org/10.1093/neuonc/noaa215.459
Autor:
Yasmin Hazrat, Carlos A. Ramos, Meng Fen Wu, Aaron E. Foster, Barbara Savoldo, Paul Castillo-Caro, A. John Barrett, Malcolm K. Brenner, Alana A. Kennedy-Nasser, Hao Liu, George Carrum, Catherine M. Bollard, Robert A. Krance, Jos Melenhorst, Stephanie Ku, Kathryn S. Leung, Helen E. Heslop, Eric Yvon, Sawa Ito
Publikováno v:
Clinical Cancer Research. 20:2215-2225
Purpose: GVHD after allogeneic hematopoietic stem cell transplantation (alloSCT) has been associated with low numbers of circulating CD4+CD25+FoxP3+ regulatory T cells (Tregs). Because Tregs express high levels of the interleukin (IL)-2 receptor, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f7ca6c49c4372b4273c2bd4486b7ae
https://doi.org/10.1158/1078-0432.ccr-13-3205
https://doi.org/10.1158/1078-0432.ccr-13-3205
Autor:
Carolina Garrido, Joann D. Kuruc, Paul Castillo-Caro, Sharon Lam, Cliona M. Rooney, David M. Margolis, Julia Sung, Conrad Russell Y. Cruz, Minhtran C. Ngo, Catherine M. Bollard, Nancie M. Archin
Antiretroviral therapy (ART) is unable to eradicate human immunodeficiency virus type 1 (HIV-1) infection. Therefore, there is an urgent need to develop novel therapies for this disease to augment anti-HIV immunity. T cell therapy is appealing in thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::089f82bad1b3d3520819d82f4a01fddd
https://europepmc.org/articles/PMC4445615/
https://europepmc.org/articles/PMC4445615/